Clinical trial · Interventional
Ultrasound for Detection of Prostate Cancer
Dual-frequency Ultrasound for Detection of Prostate Cancer
NCT05736094CI-TRIAL-00075762SURFcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SURF | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Dual-frequency ultrasound
- description
- Dual-frequency ultrasound for detection of prostate cancer
- interventionNames
- Device: SURF
Primary outcomes (2)
- measure
- Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
- timeFrame
- 1 day
- description
- Sensitivity and specificity outcome measures
- measure
- Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
- timeFrame
- 1 day
- description
- Comparing dual-frequency ultrasound, shear waves ultrasound, CEUS to MRI and histopathological findings
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years onwards * Signed written informed consent to perform rectal and transperineal ultrasound Exclusion Criteria: * N/A
References
Publications (0)
Data not yet available
No reference posted for this study.